By Reuters Staff
(Reuters) – Health insurer Centene Corp said on Monday it would buy Magellan Health Inc in a deal valued at $2.2 billion, including debt.
Centene will buy the company for $95 per share in cash, a 14.7% premium to the last closing price, the companies said in a statement.read more